|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Research Centre for the Working Environment, Denmark |
|---|---|
| Information provided by: | National Research Centre for the Working Environment, Denmark |
| ClinicalTrials.gov Identifier: | NCT01076127 |
Purpose
Neck/shoulder and back pain is quite common among employees in sedentary occupations. Furthermore, many have a low level of fitness. Strength training with dumbbells has been shown to alleviate neck/shoulder pain, but many people prefer to also have alternative training options. Empirically, kettlebell training works the neck/shoulder/back while at the same time training the cardiovascular system. This type of training has not previously been tested in a randomized controlled trial. The aim of this study is to test the effect of kettlebell training on musculoskeletal pain, fitness, and muscle strength.
| Condition | Intervention |
|---|---|
|
Musculoskeletal Disorders |
Behavioral: Ketllebell training Behavioral: Control |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Factorial Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Effect of Kettlebell Training on Musculoskeletal and Cardiovascular Health |
| Enrollment: | 40 |
| Study Start Date: | March 2010 |
| Study Completion Date: | June 2010 |
| Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Ketllebell group
Basic ketllebell training 3 x 20 min a week for 8 weeks
|
Behavioral: Ketllebell training
Kettlebell training 3 x 20 min a week for 8 weeks
|
|
Sham Comparator: Control group
Control group. Receives a health examination before and after the intervention period, and are advised to stay active.
|
Behavioral: Control
Receives a health examination before and after the intervention period, and are advised to stay active.
|
Eligibility| Ages Eligible for Study: | 20 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Denmark | |
| Novo Nordisk | |
| Copenhagen, Denmark | |
| Principal Investigator: | Lars L Andersen, PhD | National Research Centre for the Working Environment, Denmark |
More Information
| Responsible Party: | Otto Melchior Poulsen, National Research Centre for the Working Environment, Denmark |
| ClinicalTrials.gov Identifier: | NCT01076127 History of Changes |
| Other Study ID Numbers: | VIMS02 |
| Study First Received: | February 24, 2010 |
| Last Updated: | December 12, 2010 |
| Health Authority: | Denmark: The Danish National Committee on Biomedical Research Ethics |
|
Musculoskeletal Diseases |